Note: Mouseover a species abbreviation on the product page to display the fullname.
How can we help you?
![Western Blot: TFII-I Antibody [NBP1-90010] - Analysis in human cell line SH-SY5Y.](http://images.novusbio.com/fullsize/TFII-I-Antibody-Western-Blot-NBP1-90010-img0009.jpg "Western Blot: TFII-I Antibody [NBP1-90010] - Analysis in human cell line SH-SY5Y.")
![Immunocytochemistry/Immunofluorescence: TFII-I Antibody [NBP1-90010] - Staining of human cell line A-431 shows localization to nucleoplasm. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/TFII-I-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-90010-img0008.jpg)
![Immunohistochemistry-Paraffin: TFII-I Antibody [NBP1-90010] - Staining of human stomach shows strong nuclear positivity in glandular cells.](http://images.novusbio.com/fullsize/TFII-I-Antibody-Immunohistochemistry-Paraffin-NBP1-90010-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: TFII-I Antibody [NB100-61054] - FFPE section of human colon carcinoma. Affinity purified rabbit anti-GTF2I/TF II-I used at a dilution of 1:100.](http://images.novusbio.com/fullsize/TFII-I-Antibody-Immunocytochemistry-Immunofluorescence-NB100-61054-img0001.jpg "Immunocytochemistry/Immunofluorescence: TFII-I Antibody [NB100-61054] - FFPE section of human colon carcinoma. Affinity purified rabbit anti-GTF2I/TF II-I used at a dilution of 1:100.")
![Immunohistochemistry: TFII-I Antibody [NB100-61054] - Sample: FFPE section of human Ewing sarcoma (left) and mouse teratoma (right). Antibody: Affinity purified rabbit anti-GTF2I/TFII-I used at a dilution of 1:200 (1ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/TFII-I-Antibody-Immunohistochemistry-NB100-61054-img0006.jpg)
![Immunohistochemistry-Paraffin: TFII-I Antibody [NB100-61054] - FFPE section of human colon carcinoma. Affinity purified rabbit anti-GTF2I/TFII-I used at a dilution of 1:100.](http://images.novusbio.com/fullsize/TFII-I-Antibody-Immunohistochemistry-Paraffin-NB100-61054-img0002.jpg)
![Immunohistochemistry-Paraffin: TFII-I Antibody [NB100-61054] - FFPE section of human ovarian carcinoma. Affinity purified rabbit anti-GTF2I/TFII-I used at a dilution of 1:100.](http://images.novusbio.com/fullsize/TFII-I-Antibody-Immunohistochemistry-Paraffin-NB100-61054-img0003.jpg)
![Immunohistochemistry-Paraffin: TFII-I Antibody [NB100-61054] - FFPE section of mouse teratoma. Affinity purified rabbit anti-GTF2I/TFII-I used at a dilution of 1:100.](http://images.novusbio.com/fullsize/TFII-I-Antibody-Immunohistochemistry-Paraffin-NB100-61054-img0004.jpg)
![<b>Independent Antibodies Validation. </b>Immunoprecipitation: TFII-I Antibody [NB100-61054] - Detection of human GTF2I/TFII-I by western blot and immunoprecipitation. Samples: Whole cell lysate (5, 15 and 50 ug for WB; 1 mg for IP, 20% of IP loaded) from HeLa cells. Antibodies: Affinity purified rabbit anti-GTF2I/TFII-I antibody NB100-61054 used for WB at 0.04 ug/ml (A) and 1 ug/ml (B) and used for IP at 3 ug/mg lysate. GTF2I/TFII-I was also immunoprecipitated by rabbit anti-GTF2I/TFII-I antibody NB100-61053, which recognizes an upstream epitope. Detection: Chemiluminescence with exposure times of 3 seconds (A) and 1 second (B).](http://images.novusbio.com/fullsize/TFII-I-Antibody-Immunoprecipitation-NB100-61054-img0007.jpg)
![Western Blot: TFII-I Antibody [NB500-157] - Detection of Human GTF2I/TFII-I by Western Blot. Samples: Whole cell lysate (50 ug) from HeLa and 293T cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-GTF2I/TFII-I antibody NB500-157 used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.](http://images.novusbio.com/fullsize/TFII-I-Antibody-Western-Blot-NB500-157-img0007.jpg "Western Blot: TFII-I Antibody [NB500-157] - Detection of Human GTF2I/TFII-I by Western Blot. Samples: Whole cell lysate (50 ug) from HeLa and 293T cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-GTF2I/TFII-I antibody NB500-157 used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.")
![Immunohistochemistry: TFII-I Antibody [NB500-157] - Sample: FFPE section of human breast carcinoma. Antibody: Affinity purified rabbit anti-GFT2I/TF II-I used at a dilution of 1:5,000 (0.2ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/TFII-I-Antibody-Immunohistochemistry-NB500-157-img0006.jpg)
![<b>Genetic Strategies Validation. </b>Western Blot: TFII-I Antibody [NB500-157] - Whole cell lysate (100 ug) from HEK293 cells treated with GTF2I/TFII-I siRNA (+) or untreated (-). Antibody used at 0.2 ug/ml.](http://images.novusbio.com/fullsize/TFII-I-Antibody-Western-Blot-NB500-157-img0005.jpg)
![Western Blot: TFII-I Antibody [NB100-61053] - Detection of Human GTF2I/TFII-I on HeLa whole cell lysate. GTF2I/TFII-I was also immunoprecipitated by rabbit anti-GTF2I/TFII-I antibody NB100-61054.](http://images.novusbio.com/fullsize/TFII-I-Antibody-Western-Blot-NB100-61053-img0005.jpg "<b>Independent Antibodies Validation. </b>Western Blot: TFII-I Antibody [NB100-61053] - Detection of Human GTF2I/TFII-I on HeLa whole cell lysate. GTF2I/TFII-I was also immunoprecipitated by rabbit anti-GTF2I/TFII-I antibody NB100-61054.")
![<b>Independent Antibodies Validation. </b>Immunohistochemistry: TFII-I Antibody [NB100-61053] - Sample: FFPE section of human breast carcinoma (left) and mouse teratoma (right). Antibody: Affinity purified rabbit anti-GTF2I/TFII-I used at a dilution of 1:200 (1ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/TFII-I-Antibody-Immunohistochemistry-NB100-61053-img0007.jpg)
![Western Blot: TFII-I Antibody (SR1139) [NBP3-22420] - Western blot analysis using NBP3-22420 in Jurkat cell lysate.](http://images.novusbio.com/fullsize/nbp3-22420_rabbit-tfii-i-mab-sr1139-6720239533742.jpg "Western Blot: TFII-I Antibody (SR1139) [NBP3-22420] - Western blot analysis using NBP3-22420 in Jurkat cell lysate.")